-The Hindu Scientists raise concern over frequent and irresponsible use of antibiotics by animal farm industry Frequent and irresponsible use of antibiotics by the animal farm industry is leading to difficulties in treating common bacterial infections as well as post-surgery infections, a panel of scientists warned at a meeting organised by the Centre for Science and Environment (CSE) on antibiotic resistance, on Tuesday. Dr. Chand Wattal, senior consultant in the Department of Microbiology...

-The Indian Express Indian healthcare providers need to get serious about infection control. A deadly strain of bacterium has doubled its resistance to last-resort antibiotics within a year, according to the report “State of the World’s Antibiotics, 2015”. By an estimate, antimicrobial resistance — the ability of bugs to outwit antibiotics — will claim two million lives in India by 2050, a fifth of the total. India is under pressure to curb...

-The Times of India LONDON: India is the world's antibiotic popping capital, recording the highest number of such pills consumed annually — 13 billion pills as against 10 billion in China and 7 billion in the US. As a result of such reckless use, deadly strains of life-taking bacteria that are resistant to even the latest generation of antibiotics have been found to be rampant in India. The first State of the World's...

-The Telegraph New Delhi: India could prevent on average 18,000 people from developing multi-drug-resistant tuberculosis every year over the next decade if the health ministry accelerates proposed changes in TB diagnosis and treatment policies, public health experts have said. A study by the health ministry's TB division has estimated that India could avert 180,000 cases of MDR-TB between 2015 and 2025 if most patients who seek government treatment are tested for MDR-TB...

-Down to Earth TB programme grappling with lack of funds; weak enforcement of standards another problem A joint initiative of the government, independent experts and civil society has found that multidrug-resistant tuberculosis (MDR-TB) is emerging as a major health problem in India. Moreover, delay in treatment of MD-RTB is the main reason behind increasing antibiotic resistance, especially towards drug Rifampicin. The findings have been established by Joint Monitoring Mission (JMM) 2015 of...